Setmelanotide is a melanocortin-4 receptor agonist used in the clinical treatment of chronic weight management in patients with rare genetic obesity disorders, including those associated with pathogenic… Read more
Setmelanotide is a melanocortin-4 receptor agonist used in the clinical treatment of chronic weight management in patients with rare genetic obesity disorders, including those associated with pathogenic variants in MC4R, POMC, or PCSK1 genes and pediatric-onset Prader-Willi syndrome. This category includes high-quality reference standards for Setmelanotide API, as well as a comprehensive selection of pharmacopeial and non-pharmacopeial impurities and stable isotope labelled compounds. Pharmaceutical laboratories rely on these reference materials for critical analytical tasks, such as impurity profiling, method development, and validation of quantification assays. By utilizing these precise standards, researchers can ensure accurate assessment of drug purity and stability, which is essential for maintaining strict quality control standards throughout the pharmaceutical lifecycle, from early-stage research to final product release testing.